MetLife Investment Management, LLC - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 169 filers reported holding PTC THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.79 and the average weighting 0.3%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$833,204
-44.9%
37,1800.0%0.01%
-36.4%
Q2 2023$1,512,111
-16.0%
37,1800.0%0.01%
-15.4%
Q1 2023$1,800,999
+26.9%
37,1800.0%0.01%
+18.2%
Q4 2022$1,419,161
-24.0%
37,1800.0%0.01%
-31.2%
Q3 2022$1,866,436
+26.2%
37,180
+0.7%
0.02%
+33.3%
Q2 2022$1,478,374
+3.1%
36,904
-4.0%
0.01%
+20.0%
Q1 2022$1,434,159
+44.1%
38,439
+53.8%
0.01%
+25.0%
Q4 2021$995,392
+7.0%
24,9910.0%0.01%
-11.1%
Q3 2021$929,915
-12.0%
24,9910.0%0.01%
-10.0%
Q2 2021$1,056,370
-5.1%
24,991
+6.3%
0.01%
-9.1%
Q1 2021$1,113,388
-28.6%
23,514
-8.0%
0.01%
-31.2%
Q4 2020$1,560,415
+22.4%
25,568
-6.2%
0.02%
+14.3%
Q3 2020$1,274,686
-7.9%
27,2660.0%0.01%
-12.5%
Q2 2020$1,383,477
+20.2%
27,266
+5.7%
0.02%0.0%
Q1 2020$1,150,581
-7.1%
25,7920.0%0.02%
+23.1%
Q4 2019$1,238,790
+42.0%
25,7920.0%0.01%
+30.0%
Q3 2019$872,285
-24.8%
25,7920.0%0.01%
-23.1%
Q2 2019$1,160,638
+34.8%
25,792
+12.7%
0.01%
+30.0%
Q1 2019$861,090
+19.2%
22,877
+8.7%
0.01%
+11.1%
Q4 2018$722,436
-27.0%
21,0500.0%0.01%
-10.0%
Q3 2018$989,350
+39.3%
21,0500.0%0.01%
+25.0%
Q2 2018$710,000
+36.5%
21,050
+9.6%
0.01%
+33.3%
Q1 2018$520,000
+62.5%
19,2000.0%0.01%
+50.0%
Q4 2017$320,00019,2000.00%
Other shareholders
PTC THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,235,196$162,140,7423.42%
Camber Capital Management LP 3,400,000$76,1942.51%
ARMISTICE CAPITAL, LLC 6,150,000$137,821,5002.11%
GREAT POINT PARTNERS LLC 500,000$11,205,0002.04%
COWEN AND COMPANY, LLC 799,511$17,917,0411.25%
GEORGE KAISER FAMILY FOUNDATION 45,816$6,491,2111.22%
SPHERA FUNDS MANAGEMENT LTD. 218,459$4,895,6660.89%
SECTORAL ASSET MANAGEMENT INC 187,016$4,191,0290.82%
Nebula Research & Development LLC 21,858$489,8380.26%
Phocas Financial Corp. 64,701$1,450,0000.21%
View complete list of PTC THERAPEUTICS INC shareholders